This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ueki, K. Articles by Kirino, T. Search for Related Content PubMed PubMed Citation Articles by Ueki, K. Articles by Kirino, T.

Tight Association of Loss of Merlin Expression with Loss of Heterozygosity at Chromosome 22q in Sporadic Meningiomas¹

Department of Neurosurgery, The University of Tokyo Hospital, Tokyo 113-8655, Japan [K. U., C. W., Y. N., A. A., T. K.]; and Core Research for Evolutional Science and Technology (CREST), Kawaguchi 332-0012, Japan [T. K.]

Mutations of NF2, the gene for neurofibromatosis 2, are detected in 20–30% of sporadic meningiomas, and almost all mutations lead to loss of merlin expression. However, loss of heterozygosity (LOH) at chromosome 22q is found at a much higher frequency, up to 50–70%, and the possibility of another tumor suppressor gene in this region has not been excluded. Furthermore, a recent report proposed that abnormal activation of a protease µ-calpain can be an alternative pathway for merlin loss in meningiomas and schwannomas. To determine the correlation of merlin loss with NF2 genetic alteration or µ-calpain activation, we performed a molecular genetic analysis of 50 sporadic meningiomas and also examined the expression status of merlin and active form µ-calpain. LOH assay of five microsatellite markers franking NF2 revealed LOH in 22 cases, and single-strand conformation polymorphism assay detected six frameshift mutations, two splicing mutations, one nonsense mutation, and one missense mutation, all accompanied by 22q LOH. In addition, a multiplex PCR assay indicated homozygous deletion of NF2 in two cases. Interestingly, a marked decrease of merlin expression was seen exclusively in the 22 cases with 22q LOH. Activated µ-calpain expression was observed in 28 cases at various levels but showed no correlation with merlin status. These data strongly support the notion that NF2 is the sole target of 22q LOH in meningiomas and that loss of merlin expression is always caused by genetic alteration of NF2, following the classic "two hit" theory.

This article has been cited by other articles:

				M. A. Gerber, S. M. Bahr, and D. H. Gutmann Protein 4.1B/Differentially Expressed in Adenocarcinoma of the Lung-1 Functions as a Growth Suppressor in Meningioma Cells by Activating Rac1-Dependent c-Jun-NH2-kinase Signaling. Cancer Res., May 15, 2006; 66(10): 5295 - 5303. [Abstract] [Full Text] [PDF]

				W. K. Pfisterer, N. C. Hank, M. C. Preul, W. P. Hendricks, J. Pueschel, S. W. Coons, and A. C. Scheck Diagnostic and prognostic significance of genetic regional heterogeneity in meningiomas Neuro-oncol, October 1, 2004; 6(4): 290 - 299. [Abstract] [PDF]

				B. Asgharian, Y.-J. Chen, N. J. Patronas, P. L. Peghini, J. C. Reynolds, A. Vortmeyer, Z. Zhuang, D. J. Venzon, F. Gibril, and R. T. Jensen Meningiomas May Be a Component Tumor of Multiple Endocrine Neoplasia Type 1 Clin. Cancer Res., February 1, 2004; 10(3): 869 - 880. [Abstract] [Full Text] [PDF]

				J. Bostrom, B. Meyer-Puttlitz, M. Wolter, B. Blaschke, R. G. Weber, P. Lichter, K. Ichimura, V. P. Collins, and G. Reifenberger Alterations of the Tumor Suppressor Genes CDKN2A (p16INK4a), p14ARF, CDKN2B (p15INK4b), and CDKN2C (p18INK4c) in Atypical and Anaplastic Meningiomas Am. J. Pathol., August 1, 2001; 159(2): 661 - 669. [Abstract] [Full Text]

				D. H. Gutmann The neurofibromatoses: when less is more Hum. Mol. Genet., April 1, 2001; 10(7): 747 - 755. [Abstract] [Full Text] [PDF]

				J. Lasota, J. F. Fetsch, A. Wozniak, B. Wasag, R. Sciot, and M. Miettinen The Neurofibromatosis Type 2 Gene Is Mutated in Perineurial Cell Tumors : A Molecular Genetic Study of Eight Cases Am. J. Pathol., April 1, 2001; 158(4): 1223 - 1229. [Abstract] [Full Text] [PDF]

				K. Liu, L. Li, and S. N. Cohen Antisense RNA-mediated Deficiency of the Calpain Protease, nCL-4, in NIH3T3 Cells Is Associated with Neoplastic Transformation and Tumorigenesis J. Biol. Chem., September 29, 2000; 275(40): 31093 - 31098. [Abstract] [Full Text] [PDF]